Veracyte expects to double revenue with new offerings, says CEO
With three commercialized products and a new San Francisco-based facility, Veracyte’s CEO says company could double revenue in a few years.
Archives for January 14, 2016
Pfizer, Calibr enter into strategic collaboration
Calibr and Pfizer have entered into a global strategic collaboration to develop novel antibody-based therapeutic agents to treat heart failure.